| Carol Ann Ebert-gorb, O.d. | |
|
1500 Apalachee Pkwy, Tallahassee, FL 32301-3055 | |
| (850) 656-8980 | |
| (580) 656-8980 |
| Full Name | Carol Ann Ebert-gorb, O.d. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1500 Apalachee Pkwy, Tallahassee, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033509781 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPC2173 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carol Ann Ebert-gorb, O.d. 4924 Arden Forest Way, Tallahassee, FL 32309-2958 Ph: (850) 668-3693 | Carol Ann Ebert-gorb, O.d. 1500 Apalachee Pkwy, Tallahassee, FL 32301-3055 Ph: (850) 656-8980 |
News Archive
A worldwide research consortium that includes the University of Oklahoma Health Sciences Center has proven that a new drug is more effective and easier to use than current medicines in the prevention of blood clots following hip replacement surgery.
Optimer Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2010. Optimer reported a net loss for the third quarter of 2010 of $11.8 million, or $0.30 per share, which was in line with the Company's expectations. This compares to a net loss for the third quarter of 2009 of $9.4 million, or $0.28 per share. The increase in net loss was primarily due to an increase in research and development and marketing expenses.
Children's exposure to alcohol advertising during early adolescence appears to influence both beer drinking and their intentions to drink a year later, according to a RAND Corporation study.
Health researchers at the University of Leeds are helping young people take the first steps towards reducing dangerous alcohol intake through an online personal analysis of their drinking behaviour.
Omeros Corporation announced that the company recently submitted a New Drug Application to the U.S. Food and Drug Administration for approval of OMS302 for use in patients undergoing intraocular lens replacement surgery.
› Verified 4 days ago
Dr. Megan Wohlers, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1535 Centerville Rd, Tallahassee, FL 32308 Phone: 850-877-0961 | |
Todd Clayton Mcwilliams, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 2140 Centerville Pl, Tallahassee, FL 32308 Phone: 850-383-3322 | |
Big Bend Family Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 1394 Timberlane Rd, Tallahassee, FL 32312 Phone: 850-491-0107 Fax: 850-219-0077 | |
Richard D Hamilton Od Pa Optometrist Medicare: Medicare Enrolled Practice Location: 2724 Capital Cir Ne, #1, Tallahassee, FL 32308 Phone: 850-385-4444 Fax: 850-386-5383 | |
Rebecca Lassley, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2858 Mahan Dr., Suite 4, Tallahassee, FL 32308 Phone: 850-216-2020 | |
Myeyedr. Optometrist Medicare: Medicare Enrolled Practice Location: 1480 Timberlane Rd, Tallahassee, FL 32312 Phone: 850-893-4005 Fax: 850-893-9987 |